SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-20-127755
Filing Date
2020-04-30
Accepted
2020-04-30 08:22:37
Documents
5
Group Members
CONSOLIDATION MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d871135d8k.htm 425 31799
2 EX-23.1 d871135dex231.htm EX-23.1 1545
3 EX-99.1 d871135dex991.htm EX-99.1 25733
4 EX-99.2 d871135dex992.htm EX-99.2 1247025
5 EX-99.3 d871135dex993.htm EX-99.3 48024
  Complete submission text file 0001193125-20-127755.txt   1355669
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Subject) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-35837 | Film No.: 20833282
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filed by) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences